首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1569489

傷口清創市場規模、佔有率、成長分析、按產品、按傷口類型、按細分市場、按地區 - 產業預測，2024-2031 年

Wound Debridement Market Size, Share, Growth Analysis, By Product (Enzymatic Debridement Products, Autolytic Debridement Products), By Wound Type (Diabetic Foot Ulcers, Burns), By Segment (Hospitals, Clinics), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月13日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球傷口清創市場規模將為8.32億美元，從2023年的8.9357億美元成長到2031年的15.8184億美元，預計在預測期內（2024年~2031年）以年複合成長率7.4%成長。

由於全球慢性傷口、糖尿病性潰瘍和壓瘡的盛行率不斷增加，全球傷口清創市場正在強勁成長。科技的進步催生了酵素清創劑、機械清創工具和超音波設備等創新產品，增加了對高效傷口清創技術的需求。人口老化、外科手術增加和創傷等因素導致對有效傷口管理解決方案的需求不斷成長。此外，醫療保健專業人員對創傷護理重要性的認知不斷提高以及向循證實踐的轉變正在顯著影響市場動態。從地區來看，北美因其先進的醫療基礎設施、高額醫療支出以及較早採用尖端創傷護理技術而佔據市場主導地位。同時，由於醫療保健設施的改善、患者數量的增加以及醫療研發投資的增加，亞太地區正在經歷顯著的成長。市場前景光明，美國傷口清創市場預計將持續成長，未來年複合成長率（CAGR）良好。總體而言，由於越來越重視有效的創傷護理管理以及行業主要企業對創新和增強清創產品的持續承諾，全球傷口清創市場將繼續保持這種上升趨勢。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Smith & Nephew（UK）
B. Braun Melsungen AG（Germany）
Lohmann & Rauscher（Germany）
Molnlycke Health Care AB（Sweden）
Convatec（UK）
Coloplast Corp（Denmark）
Integra Lifesciences（US）
Zimmer Biomet（US）
Misonix（US）
Medline Industries（US）
Welcare Industries SP A（Italy）
Medaxis（US）
Pulsecare Medical（US）
Arobella Medical（US）
Advancis Medical（UK）
RLS Global（US）
Deroyal Industries（US）
EZ Debride（US）
Soring（Germany）
Suzhou And Science & Technology Development（China）

簡介目錄

Product Code: SQMIG35B2175

Global Wound Debridement Market size was valued at USD 832 million in 2022 and is poised to grow from USD 893.57 million in 2023 to USD 1581.84 million by 2031, growing at a CAGR of 7.40% during the forecast period (2024-2031).

The Global Wound Debridement Market is experiencing robust growth driven by the increasing prevalence of chronic wounds, diabetic ulcers, and pressure ulcers globally. The demand for efficient wound debridement techniques is heightened as advancements in technology yield innovative products like enzymatic debridement agents, mechanical debridement tools, and ultrasonic devices. Factors such as an aging population, rising surgical procedures, and traumatic injuries contribute to the expanding need for effective wound management solutions. Furthermore, a heightened awareness among healthcare professionals regarding the critical nature of wound care and the shift towards evidence-based practices significantly influence market dynamics. Geographically, North America holds a dominant position in the market, attributed to its advanced healthcare infrastructure, substantial healthcare expenditure, and early adoption of cutting-edge wound care technologies. Meanwhile, the Asia-Pacific region is witnessing remarkable growth, fueled by improvements in healthcare facilities, a larger patient demographic, and increased investments in medical research and development. The market outlook is positive, with expectations of sustained growth in the US Wound Debridement Market, supported by a favorable compound annual growth rate (CAGR) for the upcoming forecast year. Overall, the Global Wound Debridement Market is set to continue on this upward trajectory, driven by a growing emphasis on effective wound care management and the ongoing commitment of key industry players to innovate and enhance debridement offerings.

Top-down and bottom-up approaches were used to estimate and validate the size of the global wound debridement market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global wound debridement Market Segmental Analysis

Global Wound Debridement Market is segmented by Product, Wound Type, End User, and Region. Based on Product, the market is segmented into Enzymatic Debridement Products, Autolytic Debridement Products, Mechanical Debridement, Surgical Debridement Products, Ultrasonic Debridement Products, and Other Debridement Products. Based on Wound Type, the market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical & Traumatic Wounds, Burns, and Other Wounds. Based on End User, the market is segmented into Hospitals, Clinics, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global wound debridement Market

The increasing prevalence of chronic wounds, particularly diabetic ulcers and pressure ulcers, serves as a significant driver for the global wound debridement market. As the global population ages and the prevalence of lifestyle-related diseases escalates, the incidence of chronic wounds continues to rise, necessitating advanced and effective debridement techniques. This growing patient demographic requires innovative wound care solutions to enhance healing, reduce the risk of infections, and improve overall patient outcomes. Consequently, healthcare providers and patients alike are actively seeking reliable debridement products, thus boosting market demand and fostering growth within the wound care sector.

Restraints in the global wound debridement Market

A significant restraint in the global wound debridement market is the elevated cost associated with advanced wound management technologies and products. Despite their efficacy in enhancing patient outcomes and facilitating optimal wound healing, the high price tags can restrict access, particularly in underdeveloped regions and healthcare environments with limited financial resources. This financial barrier may discourage healthcare providers and patients from embracing state-of-the-art debridement solutions, leading to a slower adoption rate and ultimately constraining market expansion in specific demographics and geographical areas. Consequently, the disparity in affordability presents a notable challenge to the overall growth trajectory of the market.

Market Trends of the global wound debridement Market

The global wound debridement market is witnessing a significant trend toward the adoption of advanced technologies and techniques aimed at enhancing wound care. Healthcare providers and clinicians are increasingly utilizing innovative products such as enzymatic debridement agents, ultrasonic devices, and autolytic dressings, leading to more precise and effective debridement outcomes. This shift not only promotes improved wound healing but also minimizes patient discomfort, underscoring the market's focus on enhancing patient outcomes. The continuous incorporation of these sophisticated solutions reflects an overall commitment to optimizing the wound care process, indicating a robust and evolving landscape for the global wound debridement market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Degree of Competition
PESTEL Analysis

Wound Debridement Market by Product

Market Overview
Enzymatic Debridement Products
Autolytic Debridement Products
- Gels
- Ointments
Mechanical Debridement Products
- Medical Gauzes
- Mechanical Debridement Pads
Surgical Debridement Products
Ultrasonic Debridement Products
Other Debridement Products

Wound Debridement Market by Wound Type

Market Overview
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Surgical & Traumatic Wounds
Burns
Other Wounds

Wound Debridement Market by End User

Market Overview
Hospitals
Clinics
Other End Users

Wound Debridement Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Smith & Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lohmann & Rauscher (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molnlycke Health Care AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Convatec (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Coloplast Corp (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra Lifesciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Misonix (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Welcare Industries S.P. A (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medaxis (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pulsecare Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arobella Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advancis Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RLS Global (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Deroyal Industries (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EZ Debride (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soring (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Suzhou And Science & Technology Development (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments